Valuation GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. 04:35:08 18/08/2026 pm IST			5-day change	1st Jan Change
2,877.40 ^INR	+6.46%		+10.63%	+16.32%

03/08	GSK India first-quarter profit rises on steady vaccine demand	RE
03/08	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,81,714	2,24,319	3,29,173	4,87,432	3,86,822	4,88,431	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	26.27%	-
Enterprise Value (EV)	2,56,351	2,07,663	3,29,173	4,87,432	3,86,822	4,88,431	4,88,431
Change	-	-18.99%	58.51%	48.08%	-20.64%	26.27%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	42.1x	36.6x
PBR	10.6x	12.9x	18.5x	25x	17.1x	18.5x	15.5x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.5x	2.4x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	11.5x	10.4x
EV / Revenue	0x	0x	0x	0x	0x	11.5x	10.4x
EV / EBITDA	0x	0x	0x	0x	0x	33x	28.7x
EV / EBIT	0x	0x	0x	0x	0x	33.4x	28.7x
EV / FCF	0x	0x	0x	0x	0x	40.7x	37.1x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.46%	2.7%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.02%	1.02%
EPS ²	100	36.05	34.83	54.76	61.15	68.52	78.88
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43%	37.4%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,528	47,167
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,794	17,020
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,621	17,016
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,611	13,364
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,883.20	2,883.20
Nbr of stocks (in thousands)	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	-
Announcement Date	16/05/22	17/05/23	17/05/24	13/05/25	13/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.85x	12.21x	24.91x	0.58%	1,05500Cr
JOHNSON & JOHNSON	29.18x	-	-	2.05%	63TCr
ABBVIE INC.	31.95x	7.44x	15.46x	2.74%	44TCr
ROCHE HOLDING AG	19.84x	4.71x	11.68x	2.81%	35TCr
NOVARTIS AG	21.63x	5.59x	13.89x	2.87%	29TCr
ASTRAZENECA PLC	20.07x	4.15x	11.78x	2.12%	24TCr
AMGEN INC.	26.53x	6.9x	12.24x	2.4%	23TCr
NOVO NORDISK A/S	13.3x	4.74x	9.93x	3.86%	20TCr
GILEAD SCIENCES, INC.	-42.45x	6.16x	24.05x	2.37%	17TCr
Average	17.10x	6.49x	15.49x	2.42%	40.14TCr
Weighted average by Cap.	24.29x	8.06x	17.79x	1.99%